CPIX vs USB · rev $10.4M vs P/E 12, rev $28.66B
Cumberland Pharmaceuticals Inc (CPIX) versus U.S. Bancorp (USB) — a side-by-side from cached financials, not a winner call.
Cumberland Pharmaceuticals Inc (CPIX) is a drug manufacturers - specialty & generic company listed on US.
U.S. Bancorp (USB) is a banks - regional company listed on US.
Latest reported CPIX revenue for 2024-12-31 was $10.4M. Net income was -$1.9M. Revenue was up 14.9% from 2024-09-30 to 2024-12-31. CPIX currently screens at market cap $86.9M.
Latest reported USB revenue for 2025-12-31 was $28.66B. Net income was $7.57B. Revenue was up 4.4% from 2024-12-31 to 2025-12-31. USB currently screens at market cap $74.68B and trailing P/E 11.9.
CPIX currently screens at market cap $86.9M. USB currently screens at market cap $74.68B and trailing P/E 11.9.
Not investment advice. Open the CPIX and USB stock pages for the full models.
Not investment advice.